Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents in USD of ABERCROMBIE & FITCH CO /DE/ from Q4 2015 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of cash and cash equivalents, and cash and cash equivalents restricted to withdrawal or usage. Excludes amount for disposal group and discontinued operations. Cash includes, but is not limited to, currency on hand, demand deposits with banks or financial institutions, and other accounts with general characteristics of demand deposits. Cash equivalents include, but are not limited to, short-term, highly liquid investments that are both readily convertible to known amounts of cash and so near their maturity that they present insignificant risk of changes in value because of changes in interest rates.
Summary
ABERCROMBIE & FITCH CO /DE/ quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents history and change rate from Q4 2015 to Q3 2025.
  • ABERCROMBIE & FITCH CO /DE/ Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents for the quarter ending 01 Nov 2025 was $613M, a 11.4% decline year-over-year.
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Quarterly (USD)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, YoY Quarterly Change (%)

ABERCROMBIE & FITCH CO /DE/ Quarterly Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $613M -$78.4M -11.4% 01 Nov 2025 10-Q 05 Dec 2025
Q2 2025 $580M -$166M -22.2% 02 Aug 2025 10-Q 05 Sep 2025
Q1 2025 $519M -$353M -40.5% 03 May 2025 10-Q 06 Jun 2025
Q4 2024 $780M -$129M -14.2% 01 Feb 2025 10-Q 05 Dec 2025
Q3 2024 $691M +$32.9M +4.99% 02 Nov 2024 10-Q 05 Dec 2025
Q2 2024 $746M +$119M +19% 03 Aug 2024 10-Q 05 Sep 2025
Q1 2024 $872M +$415M +91% 04 May 2024 10-Q 06 Jun 2025
Q4 2023 $910M +$382M +72.4% 03 Feb 2024 10-Q 05 Dec 2025
Q3 2023 $658M +$391M +146% 28 Oct 2023 10-Q 06 Dec 2024
Q2 2023 $627M +$247M +65% 29 Jul 2023 10-Q 06 Sep 2024
Q1 2023 $457M -$21.8M -4.56% 29 Apr 2023 10-Q 07 Jun 2024
Q4 2022 $528M -$307M -36.8% 28 Jan 2023 10-K 31 Mar 2025
Q3 2022 $267M -$613M -69.7% 29 Oct 2022 10-Q 04 Dec 2023
Q2 2022 $380M -$556M -59.4% 30 Jul 2022 10-Q 01 Sep 2023
Q1 2022 $478M -$446M -48.2% 30 Apr 2022 10-Q 06 Jun 2023
Q4 2021 $834M -$290M -25.8% 29 Jan 2022 10-K 31 Mar 2025
Q3 2021 $880M +$48.5M +5.83% 30 Oct 2021 10-Q 06 Dec 2022
Q2 2021 $936M +$150M +19.1% 31 Jul 2021 10-Q 07 Sep 2022
Q1 2021 $924M +$202M +28% 01 May 2021 10-Q 08 Jun 2022
Q4 2020 $1.12B +$432M +62.4% 30 Jan 2021 10-K 01 Apr 2024
Q3 2020 $832M +$400M +92.5% 31 Oct 2020 10-Q 06 Dec 2021
Q2 2020 $786M +$265M +50.8% 01 Aug 2020 10-Q 08 Sep 2021
Q1 2020 $722M +$115M +18.9% 02 May 2020 10-Q 09 Jun 2021
Q4 2019 $692M -$53.6M -7.18% 01 Feb 2020 10-K 27 Mar 2023
Q3 2019 $432M -$110M -20.3% 02 Nov 2019 10-Q 07 Dec 2020
Q2 2019 $521M -$82M -13.6% 03 Aug 2019 10-Q 08 Sep 2020
Q1 2019 $608M -$7M -1.14% 04 May 2019 10-Q 10 Jun 2020
Q4 2018 $746M +$47.9M +6.86% 02 Feb 2019 10-K 28 Mar 2022
Q3 2018 $542M +$61M +12.7% 03 Nov 2018 10-Q 11 Dec 2019
Q2 2018 $603M +$160M +36.1% 04 Aug 2018 10-Q 11 Sep 2019
Q1 2018 $615M +$173M +39.1% 05 May 2018 10-Q 12 Jun 2019
Q4 2017 $698M +$130M +23% 03 Feb 2018 10-K 29 Mar 2021
Q3 2017 $481M 28 Oct 2017 10-Q 12 Dec 2018
Q2 2017 $443M 29 Jul 2017 10-Q 10 Sep 2018
Q1 2017 $442M 29 Apr 2017 10-Q 08 Jun 2018
Q4 2016 $568M -$41.5M -6.82% 28 Jan 2017 10-K 31 Mar 2020
Q4 2015 $609M 30 Jan 2016 10-K 01 Apr 2019
* An asterisk sign (*) next to the value indicates that the value is likely invalid.